These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7397697)

  • 21. A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides.
    Arano Y; Mukai T; Uezono T; Wakisaka K; Motonari H; Akizawa H; Taoka Y; Yokoyama A
    J Nucl Med; 1994 May; 35(5):890-8. PubMed ID: 8176478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying inflammation in vivo using radiolabeled antibodies and leukocytes.
    Marshall D; Haskard DO
    Methods Mol Biol; 2003; 225():273-82. PubMed ID: 12769495
    [No Abstract]   [Full Text] [Related]  

  • 23. Physiologic imaging of radiolabeled leukocytes.
    Datz FL
    Am J Physiol Imaging; 1987; 2(4):196-207. PubMed ID: 3330453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides.
    Wilbur DS
    Curr Radiopharm; 2011 Jul; 4(3):214-47. PubMed ID: 22201710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiolabelled peptides: now and the future.
    Thakur ML
    Nucl Med Commun; 1995 Sep; 16(9):724-32. PubMed ID: 7478404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiolabeling of monoclonal antibodies.
    Powe J
    Hybridoma; 1986 Jul; 5 Suppl 1():S39-42. PubMed ID: 3744384
    [No Abstract]   [Full Text] [Related]  

  • 27. Double antibody immunoradiometric assay of hGH employing a terminal labeling technique.
    Gokce A; Nakamura RM; O'Brien TJ; Tubis M; Wolf W
    Int J Nucl Med Biol; 1982; 9(4):271-5. PubMed ID: 7186498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of functionalised HP-DO3A chelating agents for conjugation to biomolecules.
    Barge A; Cappelletti E; Cravotto G; Ferrigato A; Lattuada L; Marinoni F; Tei L
    Org Biomol Chem; 2009 Sep; 7(18):3810-6. PubMed ID: 19707687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.
    Banerjee SR; Maresca KP; Francesconi L; Valliant J; Babich JW; Zubieta J
    Nucl Med Biol; 2005 Jan; 32(1):1-20. PubMed ID: 15691657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.
    Bartholomä M; Valliant J; Maresca KP; Babich J; Zubieta J
    Chem Commun (Camb); 2009 Feb; (5):493-512. PubMed ID: 19283279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of labeling conditions on the properties of 113mIn-labeled iron hydroxide particles].
    Kleinert P; Schumann E; Endert G; Klose E
    Radiobiol Radiother (Berl); 1975; 16(6):737-44. PubMed ID: 1219866
    [No Abstract]   [Full Text] [Related]  

  • 32. Assay of radiolabeled VIP binding and hydrolysis by antibodies.
    Huang H; Paul S
    Methods Mol Biol; 1995; 51():409-15. PubMed ID: 7581713
    [No Abstract]   [Full Text] [Related]  

  • 33. Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate).
    Kasina S; Sanderson JA; Fitzner JN; Srinivasan A; Rao TN; Hobson LJ; Reno JM; Axworthy DB; Beaumier PL; Fritzberg AR
    Bioconjug Chem; 1998; 9(1):108-17. PubMed ID: 9460553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of 4 radionuclides conjugated to antibodies for single-cell kill.
    Michel RB; Brechbiel MW; Mattes MJ
    J Nucl Med; 2003 Apr; 44(4):632-40. PubMed ID: 12679410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiolabeling of monoclonal antibodies.
    Saccavini JC; Bohy J; Bruneau J
    Int J Rad Appl Instrum B; 1986; 13(2):191-4. PubMed ID: 3771248
    [No Abstract]   [Full Text] [Related]  

  • 36. Bifunctional chelates for metal nuclides.
    Brechbiel MW
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):166-73. PubMed ID: 18043537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody radiolabeling, problems and promises.
    Hnatowich DJ
    Int J Rad Appl Instrum B; 1990; 17(1):49-55. PubMed ID: 2407692
    [No Abstract]   [Full Text] [Related]  

  • 38. Technical challenges associated with the radiolabeling of monoclonal antibodies utilizing short-lived, positron emitting radionuclides.
    Finn R; Cheung NK; Divgi C; St Germain J; Graham M; Pentlow K; Larson SM
    Int J Rad Appl Instrum B; 1991; 18(1):9-13. PubMed ID: 2010313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.
    Liu S
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1347-70. PubMed ID: 18538888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemoglobin radiolabeling: in vitro and in vivo comparison of iodine labeling with iodogen and a new method for technetium labeling.
    Bleeker WK; Van der Plas J; Feitsma RI; Agterberg J; Rigter G; Pauwels EK; Bakker JC
    Int J Rad Appl Instrum B; 1989; 16(4):365-9. PubMed ID: 2777576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.